Adani Gas shines post reducing CNG & PNG price
Adani Gas shines post reducing CNG & PNG price

Adani Gas shines post reducing CNG & PNG price

Avalokita Pandey Article rating: 5.0

Natural gas distribution company, Adani Gas Limited, gained more than two per cent after the company reduced prices of compressed natural gas (CNG) as well as piped natural gas (PNG).

Apollo Tyres jump after raising Rs 500 crore via NCDs
Apollo Tyres jump after raising Rs 500 crore via NCDs

Apollo Tyres jump after raising Rs 500 crore via NCDs

Avalokita Pandey Article rating: 3.0

The shares of world’s seventh largest tyre manufacturer, Apollo Tyres Ltd jumped nearly eight per cent on April 9, after the company announced that it has raised Rs 500 crore through NCDs.

L&T uses artificial intelligence to help cities combat COVID-19
L&T uses artificial intelligence to help cities combat COVID-19

L&T uses artificial intelligence to help cities combat COVID-19

Avalokita Pandey Article rating: 3.4

Larsen & Toubro (L&T) has come up with new innovative technologies such as artificial intelligence to help the local authorities in monitoring and implementing measures to combat the spread of COVID-19.

Good days for Indian Pharma ahead?
Good days for Indian Pharma ahead?

Good days for Indian Pharma ahead?

Pratik Shastri Article rating: 3.4

The key reason for this staggered performance was the lack of any strong trigger that could bring certainty in term of revenue. Further, many regulatory hurdles, such as from USFDA, also made things difficult for these companies.

Granules India gets USFDA nod for muscle contraction drugs
Granules India gets USFDA nod for muscle contraction drugs

Granules India gets USFDA nod for muscle contraction drugs

Anthony Fernandes Article rating: 4.2

Granules India informed the bourses on Thursday that its wholly-owned subsidiary, Granules Pharmaceuticals Inc has received approval from the United States Food and Drug Administration (USFDA) for Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg.

Aurobindo Pharma gains post ANDA approval
Aurobindo Pharma gains post ANDA approval

Aurobindo Pharma gains post ANDA approval

Anthony Fernandes Article rating: 3.7

The shares of Aurobindo Pharma Limited (APL) were trading in green on Thursday after the company announced that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine Tablets, 10 mg and 20 mg.

RSS
First23092310231123122314231623172318Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR